Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

595
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

4.6K
The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
4.6K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

274
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
274
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

334
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
334
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

1.0K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

363
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
363

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The possible role of physical activity in the modulation of gut microbiota in chronic kidney disease and its impact on cardiovascular risk: a narrative review.

European review for medical and pharmacological sciences·2023
Same author

Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy).

European review for medical and pharmacological sciences·2023
Same author

Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance.

European review for medical and pharmacological sciences·2023
Same author

A literature review of hypertensive retinopathy: systemic correlations and new technologies.

European review for medical and pharmacological sciences·2022
Same author

Dental unit water content and antibiotic resistance of <i>Pseudomonas aeruginosa</i> and <i>Pseudomonas</i> species: a case study.

Journal of oral microbiology·2022
Same author

The gut microbiome as possible mediator of the beneficial effects of very low calorie ketogenic diet on type 2 diabetes and obesity: a narrative review.

Eating and weight disorders : EWD·2022

Related Experiment Video

Updated: Mar 23, 2026

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

2.7K

Obesity and kidney disease: Beyond the hyperfiltration.

A Mascali1, O Franzese1, S Nisticò2

  • 1Division of Hypertension and Nephrology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy.

International Journal of Immunopathology and Pharmacology
|April 6, 2016
PubMed
Summary

Overweight and obesity contribute significantly to kidney disease, representing an emerging epidemic. This study explores how obesity directly damages kidneys, independent of diabetes and hypertension.

Keywords:
hyperfiltrationkidney diseaseobesity

More Related Videos

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

804
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.9K

Related Experiment Videos

Last Updated: Mar 23, 2026

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

2.7K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

804
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.9K

Area of Science:

  • Nephrology
  • Endocrinology
  • Public Health

Background:

  • Overweight and obesity are major contributors to kidney disease in industrialized nations, affecting 13.8% of men and 24.9% of women.
  • Obesity-associated glomerulopathy is recognized as an emerging epidemic, highlighting a critical public health concern.
  • Kidney function impairment due to obesity occurs through various direct and indirect mechanisms.

Discussion:

  • While obesity's link to type 2 diabetes and hypertension is well-known, its role in direct kidney damage is less recognized.
  • This paper focuses on the direct impact of obesity on kidney health, independent of common comorbidities.
  • The study investigates the specific contribution of adipose tissue, especially visceral fat, to obesity-induced chronic kidney damage.

Key Insights:

  • Obesity directly causes kidney damage, irrespective of hypertension and diabetes.
  • Visceral adipose tissue plays a crucial role in obesity-related kidney disease.
  • Increased awareness of obesity's independent nephrotoxic effects is critical.

Outlook:

  • Further research into the mechanisms of direct kidney damage from obesity is warranted.
  • Developing targeted interventions for obesity-related kidney disease is a priority.
  • Public health strategies should address obesity as a primary driver of chronic kidney disease.